About Quarterly Earnings Report Disclosures
| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥3.06B | ¥2.99B | +2.2% |
| Cost of Sales | ¥2.01B | ¥1.80B | +11.4% |
| Gross Profit | ¥1.05B | ¥1.19B | -11.8% |
| SG&A Expenses | ¥696M | ¥699M | -0.5% |
| Operating Income | ¥351M | ¥488M | -28.1% |
| Non-operating Income | ¥13M | ¥5M | +143.7% |
| Non-operating Expenses | ¥14M | ¥40M | -65.6% |
| Ordinary Income | ¥350M | ¥453M | -22.7% |
| Profit Before Tax | ¥353M | ¥452M | -21.9% |
| Income Tax Expense | ¥-2M | ¥150M | -101.2% |
| Net Income | ¥355M | ¥302M | +17.3% |
| Net Income Attributable to Owners | ¥354M | ¥302M | +17.2% |
| Total Comprehensive Income | ¥373M | ¥292M | +27.7% |
| Depreciation & Amortization | ¥136M | ¥135M | +0.6% |
| Interest Expense | ¥7M | ¥7M | +4.1% |
| Basic EPS | ¥129.18 | ¥108.10 | +19.5% |
| Dividend Per Share | ¥33.00 | ¥33.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥6.59B | ¥6.59B | +¥2M |
| Cash and Deposits | ¥2.74B | ¥2.85B | ¥-108M |
| Accounts Receivable | ¥1.28B | ¥1.30B | ¥-21M |
| Inventories | ¥271M | ¥239M | +¥32M |
| Non-current Assets | ¥3.37B | ¥3.26B | +¥116M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥277M | ¥313M | ¥-36M |
| Financing Cash Flow | ¥-248M | ¥-391M | +¥144M |
| Item | Value |
|---|---|
| Book Value Per Share | ¥2,542.69 |
| Net Profit Margin | 11.6% |
| Gross Profit Margin | 34.3% |
| Current Ratio | 415.6% |
| Quick Ratio | 398.5% |
| Debt-to-Equity Ratio | 0.43x |
| Interest Coverage Ratio | 51.63x |
| EBITDA Margin | 15.9% |
| Effective Tax Rate | -0.5% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +2.2% |
| Operating Income YoY Change | -28.0% |
| Ordinary Income YoY Change | -22.7% |
| Net Income Attributable to Owners YoY Change | +17.3% |
| Total Comprehensive Income YoY Change | +27.8% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 3.09M shares |
| Treasury Stock | 358K shares |
| Average Shares Outstanding | 2.75M shares |
| Book Value Per Share | ¥2,542.63 |
| EBITDA | ¥487M |
| Item | Amount |
|---|---|
| Year-End Dividend | ¥33.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| MedicalProducts | ¥1M | ¥58M |
| TechnologicalProducts | ¥2.23B | ¥448M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥6.20B |
| Operating Income Forecast | ¥750M |
| Ordinary Income Forecast | ¥730M |
| Net Income Attributable to Owners Forecast | ¥510M |
| Basic EPS Forecast | ¥185.44 |
| Dividend Per Share Forecast | ¥35.00 |
This data was automatically extracted from XBRL files. Please refer to the original disclosure documents for accuracy.
| Property, Plant & Equipment | ¥2.95B | ¥2.94B | +¥2M |
| Intangible Assets | ¥32M | ¥33M | ¥-1M |
| Investment Securities | ¥136M | ¥125M | +¥11M |
| Total Assets | ¥9.96B | ¥9.84B | +¥119M |
| Current Liabilities | ¥1.59B | ¥1.64B | ¥-54M |
| Accounts Payable | ¥169M | ¥163M | +¥6M |
| Non-current Liabilities | ¥1.42B | ¥1.50B | ¥-72M |
| Long-term Loans | ¥843M | ¥894M | ¥-51M |
| Total Liabilities | ¥3.01B | ¥3.14B | ¥-126M |
| Total Equity | ¥6.95B | ¥6.71B | +¥245M |
| Capital Stock | ¥1.94B | ¥1.94B | ¥0 |
| Capital Surplus | ¥517M | ¥517M | +¥27,000 |
| Retained Earnings | ¥4.58B | ¥4.33B | +¥254M |
| Treasury Stock | ¥-285M | ¥-256M | ¥-29M |
| Owners' Equity | ¥6.95B | ¥6.71B | +¥245M |
| Working Capital | ¥5.00B | - | - |